HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TRANSTHERA-B

10.170

-0.230-2.21%

Volume:2.48M

Turnover:25.19M

Market Cap:4.14B

PE:-11.47

High:10.370

Open:10.350

Low:10.080

Close:10.400

52wk High:679.500

52wk Low:9.010

Shares:407.00M

HK Float Shares:312.00M

Volume Ratio:0.63

T/O Rate:0.79%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.887

ROE:-36.78%

ROA:-20.32%

PB:4.04

PE(LYR):-11.47

PS:100.06

Loading ...

Overview Company News Filings

TRANSTHERA-B Shares Surge Over 8% on Approval of Phase II Trial for mCRPC Treatment

TransThera Sets 18 June 2026 Virtual AGM; Shareholders to Vote on FY 2025 Results, Auditor Renewal and Supervisory Committee Cancellation

Bulletin Express

TRANSTHERA-B Calls 18 June 2026 Virtual AGM; To Address 2025 Losses, No Dividend, Auditor Re-appointment and Governance Reshuffle

Bulletin Express

TransThera Sciences announces annual shareholder meeting

TRANSTHERA-B's Core Drug, Tinengotinib, Gains NMPA Approval for Phase II Trial in Advanced Prostate Cancer

TransThera says China NMPA clears Phase II trial of tinengotinib combo in advanced prostate cancer

TRANSTHERA-B Forges Clinical and Supply Partnership with Shanghai Allist Pharmaceuticals

Transthera Sciences (Nanjing) Inc - to Conduct Phase Ii Trial of Tt-973-MS and Firmonertinib in Advanced Nsclc

THOMSON REUTERS

Transthera Sciences (Nanjing) Inc - Co and Shanghai Allist Announce Collaboration for Nsclc Clinical Trial

THOMSON REUTERS

TransThera Sciences signs pact with Allist Pharma to study TT-00973 plus firmonertinib in EGFR-mutant NSCLC

TransThera Sets 18 June 2026 Online EGM to Approve New H Share Award Scheme and Service Provider Sublimit

Bulletin Express

TransThera Sciences Launches 2026 H-Share Award Scheme, Capping New Share Issuance at 10% of Outstanding Stock

Bulletin Express

TRANSTHERA-B Shares Drop Over 3% Following Third Fundraising via Discounted Placement This Year

Stock Track | TransThera-B Soars 6.12% Intraday Following Share Placement for Oncology Drug Development

TransThera Sciences Seeks HK$156 Million via Share Offering

MT Newswires Live

Stock Track | TRANSTHERA-B Plummets 5.22% in Pre-Market After Announcing Private Placement at 18% Discount

TransThera Sciences places 3.84 million new H-shares at HK$40.83, raising up to HK$156.62 million

Bulletin Express

TRANSTHERA-B Announces Private Placement of Shares at a Discount to Raise Capital

TransThera Sciences prices 3,836,000-share placement at HK$40.83 each

Transthera Sciences (Nanjing) Inc - to Place 3,836,000 New H Shares at HK$40.83 per Share

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/02617/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"TRANSTHERA-B","latestPrice":10.17,"timestamp":1788163726522,"preClose":10.4,"halted":0,"volume":2479500,"delay":0,"changeRate":-0.022115384615384655,"floatShares":312000000,"shares":407000000,"eps":-0.886745106646495,"marketStatus":"Not Yet Opened","change":-0.23,"latestTime":"08-31 16:08:46","open":10.35,"high":10.37,"low":10.08,"amount":25194615,"amplitude":0.027885,"askPrice":10.17,"askSize":48500,"bidPrice":10.16,"bidSize":29500,"shortable":3,"etf":0,"ttmEps":-0.7847390833653417,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788226200000},"marketStatusCode":0,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":10.4,"openAndCloseTimeList":[[1788139800000,1788148800000],[1788152400000,1788163200000]],"volumeRatio":0.630178,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":312000000,"roa":"-20.32%","roe":"-36.78%","lyrEps":-0.886702,"volumeRatio":0.630178,"shares":407000000,"dividePrice":0,"high":10.37,"amplitude":0.027885,"preClose":10.4,"low":10.08,"week52Low":9.01,"pbRate":"4.04","psRate":"100.06","week52High":679.5,"institutionHeld":0,"latestPrice":10.17,"committee":-0.24359,"eps":-0.886702411187408,"divideRate":0,"volume":2479500,"delay":0,"ttmEps":-0.7847012993446839,"open":10.35,"prevYearClose":114.9,"prevWeekClose":10.4,"prevMonthClose":9.95,"prevQuarterClose":11.55,"fiveDayClose":9.975,"twentyDayClose":10,"sixtyDayClose":33.98},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null},{"market":"HK","date":"2026-03-31","symbol":"02617","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774886400000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-25","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2026-08-28","current":-12.959722,"percent":0.869863,"low":-380.446233,"twenty":-206.454369,"median":-79.928564,"eighty":-37.623415,"high":-10.87103,"avg":-113.01539,"sd":96.275788,"marketCap":4242353783},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-27","current":-36.622688,"twenty":-34.709071,"median":-32.493198,"eighty":-31.066553,"marketCap":11013909315},{"date":"2025-07-04","current":-44.802949,"twenty":-38.622694,"median":-35.660049,"eighty":-31.776499,"marketCap":13474674640},{"date":"2025-07-11","current":-39.630155,"twenty":-40.38446,"median":-38.336544,"eighty":-32.816725,"marketCap":11906928990},{"date":"2025-07-18","current":-43.957869,"twenty":-42.111612,"median":-39.630155,"eighty":-34.373739,"marketCap":13196846297},{"date":"2025-07-25","current":-49.067594,"twenty":-42.195906,"median":-40.285196,"eighty":-36.230637,"marketCap":14784436829},{"date":"2025-08-01","current":-50.963195,"twenty":-45.655878,"median":-41.371359,"eighty":-36.620356,"marketCap":15260713988},{"date":"2025-08-08","current":-58.015216,"twenty":-51.234741,"median":-42.017389,"eighty":-37.993773,"marketCap":17415868136},{"date":"2025-08-15","current":-66.867935,"twenty":-57.065221,"median":-42.261724,"eighty":-38.707864,"marketCap":20043330466},{"date":"2025-08-22","current":-72.723484,"twenty":-59.09189,"median":-43.957869,"eighty":-39.464263,"marketCap":21730145406},{"date":"2025-08-29","current":-49.610789,"twenty":-64.458089,"median":-47.896219,"eighty":-39.630155,"marketCap":21492006826},{"date":"2025-09-05","current":-57.867887,"twenty":-63.405379,"median":-50.300475,"eighty":-39.739866,"marketCap":25044240642},{"date":"2025-09-12","current":-176.221101,"twenty":-67.557018,"median":-51.642061,"eighty":-40.181616,"marketCap":76402794352},{"date":"2025-09-19","current":-137.321051,"twenty":-71.134174,"median":-54.042597,"eighty":-40.68225,"marketCap":59494955186},{"date":"2025-09-26","current":-219.814439,"twenty":-72.736767,"median":-55.62397,"eighty":-41.23574,"marketCap":56835741045},{"date":"2025-10-03","current":-208.418403,"twenty":-113.88308,"median":-57.213624,"eighty":-41.375772,"marketCap":54017767851},{"date":"2025-10-10","current":-183.264838,"twenty":-172.633767,"median":-57.790453,"eighty":-41.583173,"marketCap":47429267143},{"date":"2025-10-17","current":-311.562728,"twenty":-178.967921,"median":-58.015216,"eighty":-41.927636,"marketCap":80570219499},{"date":"2025-10-24","current":-293.038662,"twenty":-206.454369,"median":-63.574223,"eighty":-42.029097,"marketCap":75807447903},{"date":"2025-10-31","current":-281.572204,"twenty":-212.338922,"median":-65.741367,"eighty":-42.067733,"marketCap":72949784945},{"date":"2025-11-07","current":-338.772318,"twenty":-240.199465,"median":-68.232426,"eighty":-42.195906,"marketCap":87714376893},{"date":"2025-11-14","current":-312.135011,"twenty":-262.893893,"median":-70.289151,"eighty":-42.482614,"marketCap":81046496658},{"date":"2025-11-21","current":-312.892206,"twenty":-281.392507,"median":-71.392356,"eighty":-43.133487,"marketCap":81205255711},{"date":"2025-11-28","current":-305.66478,"twenty":-292.6573,"median":-72.756691,"eighty":-44.126885,"marketCap":79617665179},{"date":"2025-12-05","current":-292.058382,"twenty":-294.387608,"median":-99.507708,"eighty":-45.187328,"marketCap":76204345536},{"date":"2025-12-12","current":-243.995471,"twenty":-293.167092,"median":-152.573856,"eighty":-47.193393,"marketCap":63781449623},{"date":"2025-12-19","current":-248.269013,"twenty":-292.997062,"median":-174.177612,"eighty":-49.176233,"marketCap":65051522048},{"date":"2025-12-24","current":-196.609225,"twenty":-292.87226,"median":-176.029803,"eighty":-49.50215,"marketCap":51676071816},{"date":"2026-01-02","current":-170.268162,"twenty":-292.367293,"median":-176.029803,"eighty":-50.024601,"marketCap":44928812055},{"date":"2026-01-09","current":-172.395935,"twenty":-291.502465,"median":-173.687618,"eighty":-50.606284,"marketCap":45603538031},{"date":"2026-01-16","current":-142.824051,"twenty":-290.689477,"median":-172.622298,"eighty":-50.90198,"marketCap":37903723951},{"date":"2026-01-23","current":-125.658859,"twenty":-289.035292,"median":-170.268162,"eighty":-51.777834,"marketCap":33316302355},{"date":"2026-01-30","current":-123.813683,"twenty":-286.862177,"median":-169.566856,"eighty":-52.840115,"marketCap":32977154367},{"date":"2026-02-06","current":-105.494623,"twenty":-283.350344,"median":-167.82666,"eighty":-53.700055,"marketCap":28169232889},{"date":"2026-02-13","current":-102.143547,"twenty":-281.033113,"median":-142.637109,"eighty":-54.549461,"marketCap":27431087268},{"date":"2026-02-20","current":-99.091969,"twenty":-280.673719,"median":-140.820404,"eighty":-54.88737,"marketCap":26573242357},{"date":"2026-02-27","current":-101.401985,"twenty":-277.873293,"median":-135.446139,"eighty":-55.077905,"marketCap":27490936913},{"date":"2026-03-06","current":-136.499284,"twenty":-268.489172,"median":-127.818396,"eighty":-56.170035,"marketCap":36707782236},{"date":"2026-03-13","current":-113.20329,"twenty":-265.946326,"median":-125.658859,"eighty":-56.966285,"marketCap":30583168569},{"date":"2026-03-20","current":-101.699451,"twenty":-264.885138,"median":-122.419285,"eighty":-57.460964,"marketCap":27371237623},{"date":"2026-03-27","current":-103.891016,"twenty":-259.5894,"median":-118.720319,"eighty":-57.713018,"marketCap":27889934546},{"date":"2026-04-02","current":-103.689961,"twenty":-256.279611,"median":-116.735022,"eighty":-57.836913,"marketCap":27969734073},{"date":"2026-04-10","current":-80.663784,"twenty":-255.242863,"median":-113.754326,"eighty":-57.879207,"marketCap":27371237623},{"date":"2026-04-17","current":-81.335146,"twenty":-254.749157,"median":-113.20329,"eighty":-57.943799,"marketCap":27610636203},{"date":"2026-04-24","current":-69.75013,"twenty":-253.791099,"median":-110.250158,"eighty":-58.025793,"marketCap":23679242293},{"date":"2026-04-30","current":-61.379887,"twenty":-252.626844,"median":-107.193308,"eighty":-58.709304,"marketCap":20850663862},{"date":"2026-05-08","current":-65.459145,"twenty":-251.564027,"median":-106.48355,"eighty":-58.020504,"marketCap":22305361341},{"date":"2026-05-15","current":-57.457667,"twenty":-249.188687,"median":-106.083059,"eighty":-57.919993,"marketCap":19630334311},{"date":"2026-05-22","current":-50.784784,"twenty":-247.674355,"median":-104.198267,"eighty":-57.649604,"marketCap":17310899997},{"date":"2026-05-29","current":-41.763424,"twenty":-245.295721,"median":-103.852131,"eighty":-57.457667,"marketCap":14285310527},{"date":"2026-06-05","current":-37.606441,"twenty":-243.995471,"median":-103.234551,"eighty":-55.321243,"marketCap":12882070430},{"date":"2026-06-12","current":-38.299212,"twenty":-239.592317,"median":-102.28828,"eighty":-53.347698,"marketCap":13110504864},{"date":"2026-06-18","current":-33.64261,"twenty":-235.649979,"median":-102.143547,"eighty":-51.161877,"marketCap":11544097313},{"date":"2026-06-26","current":-10.87103,"twenty":-223.802745,"median":-101.125662,"eighty":-50.162538,"marketCap":3712059560},{"date":"2026-07-03","current":-14.085963,"twenty":-220.323597,"median":-100.505297,"eighty":-47.51031,"marketCap":4813439869},{"date":"2026-07-10","current":-12.489761,"twenty":-217.694001,"median":-99.314488,"eighty":-43.652943,"marketCap":4262749714},{"date":"2026-07-17","current":-11.456979,"twenty":-215.893769,"median":-98.774546,"eighty":-42.55123,"marketCap":3924177249},{"date":"2026-07-24","current":-12.133097,"twenty":-213.808047,"median":-93.131819,"eighty":-41.957553,"marketCap":4156690870},{"date":"2026-07-31","current":-11.824868,"twenty":-212.088453,"median":-87.290837,"eighty":-41.541423,"marketCap":4058790398},{"date":"2026-08-07","current":-13.332054,"twenty":-210.416628,"median":-83.155604,"eighty":-40.356892,"marketCap":4585005434},{"date":"2026-08-14","current":-12.237188,"twenty":-208.788963,"median":-82.408413,"eighty":-39.630155,"marketCap":4213799478},{"date":"2026-08-21","current":-12.186563,"twenty":-208.418403,"median":-81.461274,"eighty":-38.522204,"marketCap":4205641106},{"date":"2026-08-28","current":-13.544101,"twenty":-206.454369,"median":-79.928564,"eighty":-37.623415,"marketCap":4242353783}],"updateTime":1788199234160},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02617\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1133717342","title":"TRANSTHERA-B Shares Surge Over 8% on Approval of Phase II Trial for mCRPC Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1133717342","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133717342?lang=en_us&edition=fundamental","pubTime":"2026-05-27 09:34","pubTimestamp":1779845680,"startTime":"0","endTime":"0","summary":"TRANSTHERA-B (02617) opened higher by more than 8%. As of the time of writing, the stock is up 8.12% to HK$43.92, with a turnover of HK$2.1082 million. On the news front, on May 26, TRANSTHERA-B...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK4588","BK1161","02617","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166846465","title":"TransThera Sets 18 June 2026 Virtual AGM; Shareholders to Vote on FY 2025 Results, Auditor Renewal and Supervisory Committee Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=1166846465","media":"Bulletin Express","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166846465?lang=en_us&edition=fundamental","pubTime":"2026-05-26 23:43","pubTimestamp":1779810224,"startTime":"0","endTime":"0","summary":"TransThera Sciences (Nanjing), Inc. (“TransThera-B”) has convened its 2025 annual general meeting (AGM) for 10:30 a.m. on 18 June 2026. The meeting will be held entirely online via the Vistra eVoting...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126809826","title":"TRANSTHERA-B Calls 18 June 2026 Virtual AGM; To Address 2025 Losses, No Dividend, Auditor Re-appointment and Governance Reshuffle","url":"https://stock-news.laohu8.com/highlight/detail?id=1126809826","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126809826?lang=en_us&edition=fundamental","pubTime":"2026-05-26 23:06","pubTimestamp":1779808019,"startTime":"0","endTime":"0","summary":"TRANSTHERA-B (TransThera Sciences (Nanjing), Inc.) has scheduled its 2026 Annual General Meeting (AGM) for 18 June 2026 at 10:30 a.m. via the Vistra eVoting Portal. Key items on the agenda include: •...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638545673","title":"TransThera Sciences announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2638545673","media":"Reuters","labels":["conferences","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638545673?lang=en_us&edition=fundamental","pubTime":"2026-05-26 23:06","pubTimestamp":1779807964,"startTime":"0","endTime":"0","summary":"Transthera Sciences  will hold its annual general meeting as a virtual meeting on June 18, 2026.Shareholders will vote on the 2025 board report, supervisory committee report, audited consolidated financial statements, annual report, profit distribution plan, and uncovered losses.Items also include reappointing Ernst & Young as 2026 auditor, setting 2026 pay plans for directors and supervisors, and appointing Feng Weibo as an independent director.Special resolutions cover mandates to issue shares, repurchase H shares, extend the issuance mandate by shares repurchased, and cancel the supervisory committee.Proposals also include changes to the business scope, amendments to the articles of association, and updates to related appendices.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interprete","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL3FDR9V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1095","02617","BK1615","09898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139428390","title":"TRANSTHERA-B's Core Drug, Tinengotinib, Gains NMPA Approval for Phase II Trial in Advanced Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1139428390","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139428390?lang=en_us&edition=fundamental","pubTime":"2026-05-26 21:42","pubTimestamp":1779802941,"startTime":"0","endTime":"0","summary":"TRANSTHERA-B (02617) announced that its core product, Tinengotinib (TT00420), in combination with novel hormonal therapy (NHT) for the treatment of metastatic castration-resistant prostate cancer...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638510954","title":"TransThera says China NMPA clears Phase II trial of tinengotinib combo in advanced prostate cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2638510954","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638510954?lang=en_us&edition=fundamental","pubTime":"2026-05-26 21:38","pubTimestamp":1779802730,"startTime":"0","endTime":"0","summary":"Transthera Sciences won China NMPA clearance on May 25, 2026 to start a Phase II trial of tinengotinib with novel hormone therapy in mCRPC.Study targets patients whose metastatic castration-resistant prostate cancer progressed on prior treatments; trial will assess safety, efficacy, pharmacokinetics.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transthera Sciences  Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on May 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL48My5P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150771470","title":"TRANSTHERA-B Forges Clinical and Supply Partnership with Shanghai Allist Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=1150771470","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150771470?lang=en_us&edition=fundamental","pubTime":"2026-05-26 21:38","pubTimestamp":1779802707,"startTime":"0","endTime":"0","summary":"TRANSTHERA-B (02617) has announced a clinical collaboration and drug supply agreement with Shanghai Allist Pharmaceuticals Co.,Ltd. (Shanghai Allist Pharmaceuticals). The two companies will jointly...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","02617","688578","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638751032","title":"Transthera Sciences (Nanjing) Inc - to Conduct Phase Ii Trial of Tt-973-MS and Firmonertinib in Advanced Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2638751032","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638751032?lang=en_us&edition=fundamental","pubTime":"2026-05-26 21:28","pubTimestamp":1779802135,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nFWN4230IV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638251086","title":"Transthera Sciences (Nanjing) Inc - Co and Shanghai Allist Announce Collaboration for Nsclc Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2638251086","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638251086?lang=en_us&edition=fundamental","pubTime":"2026-05-26 21:28","pubTimestamp":1779802135,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nFWN4230IV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638351080","title":"TransThera Sciences signs pact with Allist Pharma to study TT-00973 plus firmonertinib in EGFR-mutant NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2638351080","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638351080?lang=en_us&edition=fundamental","pubTime":"2026-05-26 21:28","pubTimestamp":1779802134,"startTime":"0","endTime":"0","summary":"TransThera entered a clinical trial collaboration and supply agreement with Allist to test TT-00973-MS with firmonertinib in EGFR-mutant NSCLC.Parties will run a multi-center, open-label Phase II study in locally advanced or metastatic patients to assess safety, efficacy of the combination.TransThera will sponsor the trial, covering operations and costs; Allist will supply firmonertinib mesylate tablets at no charge.Results will guide talks on a potential Phase III trial for the combination regimen.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transthera Sciences  Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on May 26, 2026, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL1VvBRZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161999293","title":"TransThera Sets 18 June 2026 Online EGM to Approve New H Share Award Scheme and Service Provider Sublimit","url":"https://stock-news.laohu8.com/highlight/detail?id=1161999293","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161999293?lang=en_us&edition=fundamental","pubTime":"2026-05-22 23:23","pubTimestamp":1779463424,"startTime":"0","endTime":"0","summary":"TransThera Sciences (Nanjing), Inc. will convene an extraordinary general meeting (EGM) on 18 June 2026 at 9:00 a.m. via the Vistra eVoting Portal. Shareholders will vote by poll on one special and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176623290","title":"TransThera Sciences Launches 2026 H-Share Award Scheme, Capping New Share Issuance at 10% of Outstanding Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1176623290","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176623290?lang=en_us&edition=fundamental","pubTime":"2026-05-22 23:23","pubTimestamp":1779463394,"startTime":"0","endTime":"0","summary":"TransThera Sciences (Nanjing), Inc. (abbrev. “TransThera Sciences”) has received shareholder approval for a new 10-year H-Share Award Scheme aimed at enhancing staff motivation, strengthening...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145272584","title":"TRANSTHERA-B Shares Drop Over 3% Following Third Fundraising via Discounted Placement This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1145272584","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145272584?lang=en_us&edition=fundamental","pubTime":"2026-05-19 11:24","pubTimestamp":1779161061,"startTime":"0","endTime":"0","summary":"TRANSTHERA-B (02617) experienced significant volatility in its share price this morning. The stock initially plunged over 9% to an intraday low of HKD 45.24 before staging a strong rebound to HKD...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK4588","02617","BK4585","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188373033","title":"Stock Track | TransThera-B Soars 6.12% Intraday Following Share Placement for Oncology Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1188373033","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188373033?lang=en_us&edition=fundamental","pubTime":"2026-05-19 10:49","pubTimestamp":1779158940,"startTime":"0","endTime":"0","summary":"TRANSTHERA-B's stock soared 6.12% during intraday trading on Tuesday, following the company's announcement of a capital raise to fund the expansion of its key drug pipeline.TransThera Sciences...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636885855","title":"TransThera Sciences Seeks HK$156 Million via Share Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2636885855","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636885855?lang=en_us&edition=fundamental","pubTime":"2026-05-19 09:38","pubTimestamp":1779154686,"startTime":"0","endTime":"0","summary":"TransThera Sciences (Nanjing) (HKG:2617) said it was looking to raise HK$156.6 million via a share offering, according to a Tuesday filing with the Hong Kong bourse.The drugmaker is seeking investors ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185523900","title":"Stock Track | TRANSTHERA-B Plummets 5.22% in Pre-Market After Announcing Private Placement at 18% Discount","url":"https://stock-news.laohu8.com/highlight/detail?id=1185523900","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185523900?lang=en_us&edition=fundamental","pubTime":"2026-05-19 09:37","pubTimestamp":1779154637,"startTime":"0","endTime":"0","summary":"TRANSTHERA-B's stock plummeted 5.22% in pre-market trading on Tuesday, following the company's announcement of a private placement of shares at a significant discount to the previous closing...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110856569","title":"TransThera Sciences places 3.84 million new H-shares at HK$40.83, raising up to HK$156.62 million","url":"https://stock-news.laohu8.com/highlight/detail?id=1110856569","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110856569?lang=en_us&edition=fundamental","pubTime":"2026-05-19 06:43","pubTimestamp":1779144200,"startTime":"0","endTime":"0","summary":"TransThera Sciences (Nanjing), Inc. disclosed a best-effort placement of 3.84 million new H-shares at HK$40.83 each, representing an 18.01 % discount to the 18 May 2026 closing price of HK$49.80 and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115520139","title":"TRANSTHERA-B Announces Private Placement of Shares at a Discount to Raise Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=1115520139","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115520139?lang=en_us&edition=fundamental","pubTime":"2026-05-19 06:40","pubTimestamp":1779144031,"startTime":"0","endTime":"0","summary":"TRANSTHERA-B (02617) has announced that on May 19, 2026, prior to the trading session, the company entered into a placement agreement with a placement agent. Under this agreement, the placement...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636800401","title":"TransThera Sciences prices 3,836,000-share placement at HK$40.83 each","url":"https://stock-news.laohu8.com/highlight/detail?id=2636800401","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636800401?lang=en_us&edition=fundamental","pubTime":"2026-05-19 06:31","pubTimestamp":1779143470,"startTime":"0","endTime":"0","summary":"Transthera Sciences  launched a best-efforts private placement of 3,836,000 new H shares at HK$ 40.83 each, targeting at least six professional or institutional investors.Gross proceeds expected at about HK$ 156.62 million; net proceeds estimated at about HK$ 152.13 million.The placement price implies an 18.01% discount to the May 18 close of HK$ 49.8.Proceeds earmarked mainly for development of new indications for tinengotinib, with the balance for working capital and general corporate purposes.Shares are expected to be issued on May 27, subject to listing approval, with the new stock representing about 0.95% of existing issued shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transthera Sciences  Inc. published the original cont","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nNDL2D9Vh3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636040990","title":"Transthera Sciences (Nanjing) Inc - to Place 3,836,000 New H Shares at HK$40.83 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2636040990","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636040990?lang=en_us&edition=fundamental","pubTime":"2026-05-19 06:30","pubTimestamp":1779143448,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nFWN41V1H7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":5,"totalSize":148,"code":"91000000","status":"200"}]}}